ONTOLOGY REPORT - ANNOTATIONS
| Term: | Osteochondrodysplasias |
|
| Accession: | RDO:0000496
|
browse the term
|
| Definition: | Abnormal development of cartilage and bone. |
| Synonyms: | exact_synonym: | CHONDRODYSTROPHIC MYOTONIA; Chondrodystrophic Myotonias; Dyschondroplasia; Dyschondroplasias; ENDOSTEAL HYPEROSTOSIS, AUTOSOMAL RECESSIVE; HYPERPHOSPHATASEMIA TARDA; Hyperostosis Corticalis Generalisata; Hyperphosphatasemia Tardas; MNS; MYOTONIC MYOPATHY, DWARFISM, CHONDRODYSTROPHY, AND OCULAR AND FACIAL ABNORMALITIES; Melnick Needles Osteodysplasty; Melnick Needles Syndrome; Multiple Epiphyseal Dysplasia; Multiple Epiphyseal Dysplasias; Myotonic chondrodystrophies; Myotonic chondrodystrophy; Osteochondrodysplasia; Osteodysplasty of Melnick and Needles; SCHWARTZ-JAMPEL SYNDROME, TYPE 1; SJA SYNDROME; SJA Syndromes; SJS; SJS1; Schwartz Jampel Aberfeld syndrome; Schwartz Jampel Syndrome; Spondylo-epimetaphyseal dysplasia with myotonia; Spondyloepiphyseal Dysplasia; Spondyloepiphyseal Dysplasias; VAN BUCHEM DISEASE; VBCH; Van Buchem Diseases |
| | primary_id: | MESH:D010009 |
| | alt_id: | OMIM:120140; OMIM:120210; OMIM:239100; OMIM:255800; OMIM:309350 |
|
|
Osteochondrodysplasias
|
| G |
Bmpr1b |
bone morphogenetic protein receptor, type IB |
|
|
ISS |
2 |
239,727,569 |
239,767,802 |
RGD:1600593 |
RGD |
| G |
Chst3 |
carbohydrate (chondroitin 6) sulfotransferase 3 |
|
|
ISS |
20 |
27,480,448 |
27,482,990 |
RGD:1600853 |
RGD |
| G |
Col10a1 |
collagen, type X, alpha 1 |
|
Susceptibility |
ISS |
20 |
38,725,164 |
38,731,513 |
RGD:1600880 |
RGD |
| G |
Col11a2 |
collagen, type XI, alpha 2 |
|
Susceptibility |
ISS |
20 |
4,924,452 |
4,953,310 |
RGD:1600883 |
RGD |
| G |
Col2a1 |
collagen, type II, alpha 1 |
|
|
ISS |
7 |
136,679,219 |
136,707,976 |
RGD:704404 |
RGD |
| G |
Col2a1 |
collagen, type II, alpha 1 |
|
|
ISS |
7 |
136,679,219 |
136,707,976 |
RGD:7240710 |
OMIM |
| G |
Col9a1 |
collagen, type IX, alpha 1 |
|
Susceptibility |
ISS |
9 |
22,907,157 |
22,990,836 |
RGD:1600949 |
RGD |
| G |
Col9a1 |
collagen, type IX, alpha 1 |
|
|
ISS |
9 |
22,907,157 |
22,990,836 |
RGD:7240710 |
OMIM |
| G |
Col9a2 |
collagen, type IX, alpha 2 |
|
Susceptibility |
ISS |
5 |
141,623,365 |
141,640,224 |
RGD:1600952 |
RGD |
| G |
Col9a3 |
collagen, type IX, alpha 3 |
|
|
ISS |
3 |
169,704,893 |
169,712,492 |
RGD:1600695 |
RGD |
| G |
Comp |
cartilage oligomeric matrix protein |
|
|
ISS |
|
|
|
RGD:1600702 |
RGD |
| G |
Comp |
cartilage oligomeric matrix protein |
|
|
ISS |
|
|
|
RGD:1600705 |
RGD |
| G |
Dym |
dymeclin |
|
|
ISS |
18 |
71,889,053 |
72,188,251 |
RGD:1598787 |
RGD |
| G |
Eif2ak3 |
eukaryotic translation initiation factor 2 alpha kinase 3 |
|
|
ISS |
4 |
104,016,940 |
104,078,261 |
RGD:734923 |
RGD |
| G |
Flna |
filamin A, alpha |
|
|
ISS |
X |
160,362,334 |
160,385,626 |
RGD:1598954 |
RGD |
| G |
Flna |
filamin A, alpha |
|
|
ISS |
X |
160,362,334 |
160,385,626 |
RGD:7240710 |
OMIM |
| G |
Flnb |
filamin B, beta |
|
|
ISS |
15 |
18,949,027 |
19,082,504 |
RGD:1601168 |
RGD |
| G |
Hapln1 |
hyaluronan and proteoglycan link protein 1 |
|
|
ISS |
2 |
19,576,064 |
19,638,106 |
RGD:734826 |
RGD |
| G |
Hspg2 |
heparan sulfate proteoglycan 2 |
|
|
ISS |
|
|
|
RGD:7240710 |
OMIM |
| G |
Hspg2 |
heparan sulfate proteoglycan 2 |
|
Susceptibility |
ISS |
|
|
|
RGD:1624267 |
RGD |
| G |
Lifr |
leukemia inhibitory factor receptor alpha |
|
|
ISS |
2 |
56,426,058 |
56,477,198 |
RGD:1600614 |
RGD |
| G |
Matn3 |
matrilin 3 |
|
|
ISS |
6 |
32,439,372 |
32,459,031 |
RGD:1599920 |
RGD |
| G |
Matn3 |
matrilin 3 |
|
|
ISS |
6 |
32,439,372 |
32,459,031 |
RGD:1599919 |
RGD |
| G |
Pth1r |
parathyroid hormone 1 receptor |
|
Susceptibility |
ISS |
8 |
115,099,763 |
115,119,362 |
RGD:1599978 |
RGD |
| G |
Slc26a2 |
solute carrier family 26 (sulfate transporter), member 2 |
|
|
IAGP |
18 |
57,170,814 |
57,184,489 |
RGD:1600010 |
RGD |
| G |
Smarcal1 |
Swi/SNF related matrix associated, actin dependent regulator of chromatin, subfamily a-like 1 |
|
|
ISS |
9 |
71,780,870 |
71,827,780 |
RGD:1599053 |
RGD |
| G |
Sost |
sclerostin |
|
|
ISS |
10 |
91,023,712 |
91,026,759 |
RGD:7240710 |
OMIM |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
Susceptibility |
ISS |
1 |
80,894,705 |
80,911,020 |
RGD:1601550 |
RGD |
| G |
Tgfb2 |
transforming growth factor, beta 2 |
|
|
IEP |
13 |
102,718,703 |
102,818,768 |
RGD:2302024 |
RGD |
| G |
Tgfbr1 |
transforming growth factor, beta receptor 1 |
|
|
IPM |
5 |
63,976,868 |
64,034,058 |
RGD:2302024 |
RGD |
| G |
Trps1 |
trichorhinophalangeal syndrome I |
|
|
ISS |
7 |
86,855,378 |
87,076,668 |
RGD:1599670 |
RGD |
Achondrogenesis type 1A
|
| G |
Trip11 |
thyroid hormone receptor interactor 11 |
|
|
ISS |
6 |
126,119,081 |
126,188,777 |
RGD:7240710 |
OMIM |
Achondrogenesis type 1B
|
| G |
Slc26a2 |
solute carrier family 26 (sulfate transporter), member 2 |
|
|
ISS |
18 |
57,170,814 |
57,184,489 |
RGD:7240710 |
OMIM |
Achondrogenesis type 2
|
| G |
Col2a1 |
collagen, type II, alpha 1 |
|
|
ISS |
7 |
136,679,219 |
136,707,976 |
RGD:7240710 |
OMIM |
Achondroplasia
|
| G |
Fgfr3 |
fibroblast growth factor receptor 3 |
|
|
ISS |
14 |
82,683,191 |
82,697,229 |
RGD:704404 |
RGD |
| G |
Fgfr3 |
fibroblast growth factor receptor 3 |
|
|
ISS |
14 |
82,683,191 |
82,697,229 |
RGD:1598937 |
RGD |
| G |
Fgfr3 |
fibroblast growth factor receptor 3 |
|
|
ISS |
14 |
82,683,191 |
82,697,229 |
RGD:7240710 |
OMIM |
| G |
Npr2 |
natriuretic peptide receptor B/guanylate cyclase B (atrionatriuretic peptide receptor B) |
|
|
ISS |
5 |
60,107,563 |
60,127,960 |
RGD:1580771 |
RGD |
Acromesomelic dysplasia Hunter-Thompson type
|
| G |
Gdf5 |
growth differentiation factor 5 |
|
|
ISS |
|
|
|
RGD:7240710 |
OMIM |
Anauxetic dysplasia
|
| G |
Rmrp |
RNA component of mitochondrial RNA processing endoribonuclease |
|
|
ISS |
15 |
26,789,869 |
26,790,125 |
RGD:7240710 |
OMIM |
Asphyxiating Thoracic Dystrophy 2
|
| G |
Ift80 |
intraflagellar transport 80 homolog (Chlamydomonas) |
|
|
ISS |
2 |
158,892,673 |
158,987,059 |
RGD:7240710 |
OMIM |
Asphyxiating Thoracic Dystrophy 3
|
| G |
Dync2h1 |
dynein cytoplasmic 2 heavy chain 1 |
|
|
ISS |
8 |
3,826,843 |
4,072,644 |
RGD:7240710 |
OMIM |
Atelosteogenesis type 2
|
| G |
Slc26a2 |
solute carrier family 26 (sulfate transporter), member 2 |
|
|
ISS |
18 |
57,170,814 |
57,184,489 |
RGD:7240710 |
OMIM |
Atelosteogenesis, type 1
|
| G |
Flnb |
filamin B, beta |
|
|
ISS |
15 |
18,949,027 |
19,082,504 |
RGD:7240710 |
OMIM |
| G |
Sct |
secretin |
|
|
ISS |
1 |
201,472,250 |
201,472,944 |
RGD:7240710 |
OMIM |
ATELOSTEOGENESIS, TYPE III
|
| G |
Flnb |
filamin B, beta |
|
|
ISS |
15 |
18,949,027 |
19,082,504 |
RGD:7240710 |
OMIM |
| G |
Sct |
secretin |
|
|
ISS |
1 |
201,472,250 |
201,472,944 |
RGD:7240710 |
OMIM |
Boomerang dysplasia
|
| G |
Flnb |
filamin B, beta |
|
|
ISS |
15 |
18,949,027 |
19,082,504 |
RGD:7240710 |
OMIM |
| G |
Sct |
secretin |
|
|
ISS |
1 |
201,472,250 |
201,472,944 |
RGD:7240710 |
OMIM |
Brachyolmia Type 3
|
| G |
Trpv4 |
transient receptor potential cation channel, subfamily V, member 4 |
|
|
ISS |
12 |
43,226,933 |
43,265,889 |
RGD:7240710 |
OMIM |
Bruck syndrome 2
|
| G |
Plod2 |
procollagen lysine, 2-oxoglutarate 5-dioxygenase 2 |
|
|
ISS |
8 |
97,525,279 |
97,623,152 |
RGD:7240710 |
OMIM |
Buschke-Ollendorff syndrome
|
| G |
Lemd3 |
LEM domain containing 3 |
|
|
ISS |
7 |
60,232,118 |
60,281,459 |
RGD:7240710 |
OMIM |
Camurati-Engelmann Syndrome
|
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
|
ISS |
1 |
80,894,705 |
80,911,020 |
RGD:7240710 |
OMIM |
Cartilage-hair hypoplasia
|
| G |
Rmrp |
RNA component of mitochondrial RNA processing endoribonuclease |
|
|
ISS |
15 |
26,789,869 |
26,790,125 |
RGD:7240710 |
OMIM |
Cherubism
|
| G |
Sh3bp2 |
SH3-domain binding protein 2 |
|
|
ISS |
14 |
81,818,728 |
81,855,875 |
RGD:1599339 |
RGD |
| G |
Sh3bp2 |
SH3-domain binding protein 2 |
|
|
ISS |
14 |
81,818,728 |
81,855,875 |
RGD:7240710 |
OMIM |
Chondrodysplasia Punctata
|
| G |
Arse |
arylsulfatase E (chondrodysplasia punctata 1) |
|
Susceptibility |
ISS |
2 |
122,663,037 |
122,670,111 |
RGD:1599238 |
RGD |
| G |
Ebp |
emopamil binding protein (sterol isomerase) |
|
|
ISS |
X |
26,331,199 |
26,337,542 |
RGD:734908 |
RGD |
Chondrodysplasia punctata 2, X-linked dominant
|
| G |
Ebp |
emopamil binding protein (sterol isomerase) |
|
|
ISS |
X |
26,331,199 |
26,337,542 |
RGD:7240710 |
OMIM |
Chondrodysplasia punctata, brachytelephalangic
|
| G |
Arse |
arylsulfatase E (chondrodysplasia punctata 1) |
|
|
ISS |
2 |
122,663,037 |
122,670,111 |
RGD:7240710 |
OMIM |
Chondrodysplasia Punctata, Rhizomelic
|
| G |
Agps |
alkylglycerone phosphate synthase |
|
|
ISS |
|
|
|
RGD:1300366 |
RGD |
| G |
Gnpat |
glyceronephosphate O-acyltransferase |
|
|
ISS |
19 |
55,033,777 |
55,059,491 |
RGD:704404 |
RGD |
| G |
Pex7 |
peroxisomal biogenesis factor 7 |
|
|
ISS |
1 |
15,099,265 |
15,163,734 |
RGD:704404 |
RGD |
| G |
Pex7 |
peroxisomal biogenesis factor 7 |
|
|
ISS |
1 |
15,099,265 |
15,163,734 |
RGD:7240710 |
OMIM |
Chondrodysplasia, Grebe type
|
| G |
Gdf5 |
growth differentiation factor 5 |
|
|
ISS |
|
|
|
RGD:7240710 |
OMIM |
Cleidocranial Dysplasia
|
| G |
Runx2 |
runt-related transcription factor 2 |
|
|
ISS |
9 |
11,869,234 |
12,025,219 |
RGD:1601649 |
RGD |
| G |
Runx2 |
runt-related transcription factor 2 |
|
|
ISS |
9 |
11,869,234 |
12,025,219 |
RGD:7240710 |
OMIM |
Dyggve-Melchior-Clausen syndrome
|
| G |
Dym |
dymeclin |
|
|
ISS |
18 |
71,889,053 |
72,188,251 |
RGD:7240710 |
OMIM |
Ectodermal Dysplasia, Anhidrotic, with Immunodeficiency, Osteopetrosis, and Lymphedema
|
| G |
Ikbkg |
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma |
|
|
ISS |
X |
160,386,558 |
160,420,190 |
RGD:7240710 |
OMIM |
Ellis-Van Creveld Syndrome
|
| G |
Evc |
Ellis van Creveld syndrome |
|
|
ISS |
14 |
79,020,120 |
79,060,046 |
RGD:1302823 |
RGD |
| G |
Evc |
Ellis van Creveld syndrome |
|
|
ISS |
14 |
79,020,120 |
79,060,046 |
RGD:7240710 |
OMIM |
| G |
Evc2 |
Ellis van Creveld syndrome 2 |
|
Susceptibility |
ISS |
14 |
78,915,869 |
79,018,416 |
RGD:1600212 |
RGD |
| G |
Evc2 |
Ellis van Creveld syndrome 2 |
|
|
ISS |
14 |
78,915,869 |
79,018,416 |
RGD:7240710 |
OMIM |
Epiphyseal dysplasia, multiple, 1
|
| G |
Comp |
cartilage oligomeric matrix protein |
|
|
ISS |
|
|
|
RGD:7240710 |
OMIM |
Epiphyseal dysplasia, multiple, 2
|
| G |
Col9a2 |
collagen, type IX, alpha 2 |
|
|
ISS |
5 |
141,623,365 |
141,640,224 |
RGD:7240710 |
OMIM |
Epiphyseal dysplasia, multiple, 3
|
| G |
Col9a3 |
collagen, type IX, alpha 3 |
|
|
ISS |
3 |
169,704,893 |
169,712,492 |
RGD:7240710 |
OMIM |
Epiphyseal dysplasia, multiple, 4
|
| G |
Slc26a2 |
solute carrier family 26 (sulfate transporter), member 2 |
|
|
ISS |
18 |
57,170,814 |
57,184,489 |
RGD:7240710 |
OMIM |
Epiphyseal dysplasia, multiple, 5
|
| G |
Matn3 |
matrilin 3 |
|
|
ISS |
6 |
32,439,372 |
32,459,031 |
RGD:7240710 |
OMIM |
Epiphyseal Dysplasia, Multiple, with Myopia and Conductive Deafness
|
| G |
Col2a1 |
collagen, type II, alpha 1 |
|
|
ISS |
7 |
136,679,219 |
136,707,976 |
RGD:7240710 |
OMIM |
Exostoses, Multiple Hereditary
|
| G |
Ext1 |
exostosin glycosyltransferase 1 |
|
|
ISS |
7 |
89,392,837 |
89,671,523 |
RGD:1598916 |
RGD |
EXOSTOSES, MULTIPLE, TYPE I
|
| G |
Ext1 |
exostosin glycosyltransferase 1 |
|
|
ISS |
7 |
89,392,837 |
89,671,523 |
RGD:7240710 |
OMIM |
EXOSTOSES, MULTIPLE, TYPE II
|
| G |
Ext2 |
exostosin glycosyltransferase 2 |
|
|
ISS |
3 |
78,111,436 |
78,244,444 |
RGD:7240710 |
OMIM |
Fairbank disease
|
| G |
Comp |
cartilage oligomeric matrix protein |
|
|
ISS |
|
|
|
RGD:7240710 |
OMIM |
Fibrous Dysplasia, Polyostotic
|
| G |
Gnas |
GNAS complex locus |
|
|
ISS |
3 |
165,213,399 |
165,214,551 |
RGD:1580402 |
RGD |
| G |
Gnas |
GNAS complex locus |
|
|
ISS |
3 |
165,213,399 |
165,214,551 |
RGD:1601378 |
RGD |
| G |
Gnas |
GNAS complex locus |
|
|
ISS |
3 |
165,213,399 |
165,214,551 |
RGD:7240710 |
OMIM |
Frontometaphyseal dysplasia
|
| G |
Flna |
filamin A, alpha |
|
|
ISS |
X |
160,362,334 |
160,385,626 |
RGD:7240710 |
OMIM |
Ghosal Hematodiaphyseal Dysplasia
|
| G |
Tbxas1 |
thromboxane A synthase 1, platelet |
|
|
ISS |
4 |
66,502,253 |
66,677,538 |
RGD:7240710 |
OMIM |
HYDROPS-ECTOPIC CALCIFICATION-MOTH-EATEN SKELETAL DYSPLASIA
|
| G |
Lbr |
lamin B receptor |
|
|
ISS |
13 |
97,814,439 |
97,834,860 |
RGD:7240710 |
OMIM |
HYPEROSTOSIS CORTICALIS GENERALISATA, BENIGN FORM OF WORTH, WITH TORUS PALATINUS
|
| G |
Lrp5 |
low density lipoprotein receptor-related protein 5 |
|
|
ISS |
1 |
206,102,750 |
206,206,350 |
RGD:7240710 |
OMIM |
Hyperostosis, Cortical, Congenital
|
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
|
ISS |
10 |
83,622,438 |
83,639,368 |
RGD:5688296 |
RGD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
|
ISS |
10 |
83,622,438 |
83,639,368 |
RGD:7240710 |
OMIM |
| G |
Sost |
sclerostin |
|
|
ISS |
10 |
91,023,712 |
91,026,759 |
RGD:68858 |
RGD |
Hypoparathyroidism-retardation-dysmorphism syndrome
|
| G |
Tbce |
tubulin folding cofactor E |
|
|
ISS |
17 |
59,485,451 |
59,533,041 |
RGD:7240710 |
OMIM |
Intrauterine Growth Retardation, Metaphyseal Dysplasia, Adrenal Hypoplasia Congenita, And Genital Anomalies
|
| G |
Cdkn1c |
cyclin-dependent kinase inhibitor 1C |
|
|
ISS |
1 |
203,835,215 |
203,837,844 |
RGD:7240710 |
OMIM |
Kenny-Caffey syndrome, Type 1
|
| G |
Tbce |
tubulin folding cofactor E |
|
|
ISS |
17 |
59,485,451 |
59,533,041 |
RGD:7240710 |
OMIM |
Larsen syndrome, dominant type
|
| G |
Flnb |
filamin B, beta |
|
|
ISS |
15 |
18,949,027 |
19,082,504 |
RGD:7240710 |
OMIM |
| G |
Sct |
secretin |
|
|
ISS |
1 |
201,472,250 |
201,472,944 |
RGD:7240710 |
OMIM |
Marshall syndrome
|
| G |
Col11a1 |
collagen, type XI, alpha 1 |
|
|
ISS |
2 |
209,996,467 |
210,193,379 |
RGD:7240710 |
OMIM |
Melorheostosis
|
| G |
Lemd3 |
LEM domain containing 3 |
|
|
ISS |
7 |
60,232,118 |
60,281,459 |
RGD:7240710 |
OMIM |
Metachondromatosis
|
| G |
Ptpn11 |
protein tyrosine phosphatase, non-receptor type 11 |
|
|
ISS |
12 |
36,501,886 |
36,558,055 |
RGD:7240710 |
OMIM |
Metaphyseal Anadysplasia 2
|
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
|
ISS |
3 |
155,985,473 |
155,993,433 |
RGD:7240710 |
OMIM |
Metaphyseal chondrodysplasia Schmid type
|
| G |
Col10a1 |
collagen, type X, alpha 1 |
|
|
ISS |
20 |
38,725,164 |
38,731,513 |
RGD:7240710 |
OMIM |
Metaphyseal Dysplasia without Hypotrichosis
|
| G |
Rmrp |
RNA component of mitochondrial RNA processing endoribonuclease |
|
|
ISS |
15 |
26,789,869 |
26,790,125 |
RGD:7240710 |
OMIM |
Metatropic dwarfism
|
| G |
Trpv4 |
transient receptor potential cation channel, subfamily V, member 4 |
|
|
ISS |
12 |
43,226,933 |
43,265,889 |
RGD:7240710 |
OMIM |
Microcephalic Osteodysplastic Primordial Dwarfism, Type II
|
| G |
Pcnt |
pericentrin |
|
|
ISS |
20 |
12,608,650 |
12,694,390 |
RGD:7240710 |
OMIM |
Osteoarthritis with Mild Chondrodysplasia
|
| G |
Col2a1 |
collagen, type II, alpha 1 |
|
|
ISS |
7 |
136,679,219 |
136,707,976 |
RGD:7240710 |
OMIM |
Osteogenesis Imperfecta
|
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
|
ISS |
10 |
83,622,438 |
83,639,368 |
RGD:734802 |
RGD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
|
ISS |
10 |
83,622,438 |
83,639,368 |
RGD:7240710 |
OMIM |
| G |
Col1a2 |
collagen, type I, alpha 2 |
|
|
ISS |
4 |
29,393,645 |
29,428,572 |
RGD:1581197 |
RGD |
| G |
Col1a2 |
collagen, type I, alpha 2 |
|
|
ISS |
4 |
29,393,645 |
29,428,572 |
RGD:704404 |
RGD |
Osteogenesis imperfecta, type 2A
|
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
|
ISS |
10 |
83,622,438 |
83,639,368 |
RGD:7240710 |
OMIM |
| G |
Col1a2 |
collagen, type I, alpha 2 |
|
|
ISS |
4 |
29,393,645 |
29,428,572 |
RGD:7240710 |
OMIM |
Osteogenesis imperfecta, type 3
|
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
|
ISS |
10 |
83,622,438 |
83,639,368 |
RGD:7240710 |
OMIM |
| G |
Col1a2 |
collagen, type I, alpha 2 |
|
|
ISS |
4 |
29,393,645 |
29,428,572 |
RGD:7240710 |
OMIM |
Osteogenesis imperfecta, type 4
|
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
|
ISS |
10 |
83,622,438 |
83,639,368 |
RGD:7240710 |
OMIM |
| G |
Col1a2 |
collagen, type I, alpha 2 |
|
|
ISS |
4 |
29,393,645 |
29,428,572 |
RGD:7240710 |
OMIM |
Osteogenesis imperfecta, type 5
|
| G |
Ifitm5 |
interferon induced transmembrane protein 5 |
|
|
ISS |
1 |
201,128,654 |
201,129,995 |
RGD:7240710 |
OMIM |
Osteogenesis imperfecta, type 7
|
| G |
Crtap |
cartilage associated protein |
|
|
ISS |
8 |
118,765,925 |
118,773,673 |
RGD:7240710 |
OMIM |
Osteogenesis Imperfecta, Type IX
|
| G |
Ppib |
peptidylprolyl isomerase B |
|
|
ISS |
8 |
70,343,463 |
70,349,320 |
RGD:7240710 |
OMIM |
Osteogenesis imperfecta, type VIII
|
| G |
Lepre1 |
leucine proline-enriched proteoglycan (leprecan) 1 |
|
|
ISS |
5 |
139,816,323 |
139,831,409 |
RGD:7240710 |
OMIM |
Osteoglophonic dwarfism
|
| G |
Fgfr1 |
Fibroblast growth factor receptor 1 |
|
|
ISS |
16 |
70,869,974 |
70,910,045 |
RGD:7240710 |
OMIM |
Osteopetrosis
|
| G |
Ca2 |
carbonic anhydrase 2 |
|
Susceptibility |
ISS |
2 |
88,077,095 |
88,092,223 |
RGD:1600698 |
RGD |
| G |
Clcn7 |
chloride channel, voltage-sensitive 7 |
|
|
ISS |
10 |
14,379,803 |
14,403,898 |
RGD:737783 |
RGD |
| G |
Clcn7 |
chloride channel, voltage-sensitive 7 |
|
|
ISS |
10 |
14,379,803 |
14,403,898 |
RGD:704404 |
RGD |
| G |
Clcn7 |
chloride channel, voltage-sensitive 7 |
|
|
ISS |
10 |
14,379,803 |
14,403,898 |
RGD:7240710 |
OMIM |
| G |
Csf1 |
colony stimulating factor 1 (macrophage) |
|
|
IAGP |
2 |
203,292,765 |
203,307,968 |
RGD:628338 |
RGD |
| G |
Ctsk |
cathepsin K |
|
|
ISS |
2 |
190,394,854 |
190,405,668 |
RGD:734856 |
RGD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
|
ISS |
6 |
109,559,135 |
109,562,001 |
RGD:704404 |
RGD |
| G |
Fosl1 |
fos-like antigen 1 |
|
|
ISS |
1 |
208,090,612 |
208,099,118 |
RGD:737712 |
RGD |
| G |
Ghr |
growth hormone receptor |
|
|
IEP |
2 |
52,496,517 |
52,658,066 |
RGD:2307374 |
RGD |
| G |
Jun |
jun proto-oncogene |
|
|
ISS |
5 |
115,358,166 |
115,361,259 |
RGD:1549450 |
RGD |
| G |
Tcirg1 |
T-cell, immune regulator 1, ATPase, H+ transporting, lysosomal V0 subunit A3 |
|
|
ISS |
1 |
206,420,106 |
206,429,495 |
RGD:1599350 |
RGD |
| Q |
Bss98 |
Bone structure and strength QTL 98 |
|
|
IAGP |
15 |
1,007,318 |
16,365,960 |
RGD:5684953 |
RGD |
| Q |
Bss99 |
Bone structure and strength QTL 99 |
|
|
IAGP |
|
|
|
RGD:5684953 |
RGD |
| S |
LEW-tl.BN-(D2Arb16-D2Wox8) |
|
|
|
TAS |
2 |
198,312,439 |
212,776,982 |
RGD:1004 |
RGD |
| S |
LEW-tl.BN-(D2Arb16-D2Wox8) |
|
|
|
TAS |
2 |
198,312,439 |
212,776,982 |
RGD:619693 |
RGD |
Osteopetrosis autosomal dominant type 1
|
| G |
Lrp5 |
low density lipoprotein receptor-related protein 5 |
|
|
ISS |
1 |
206,102,750 |
206,206,350 |
RGD:7240710 |
OMIM |
Osteopetrosis with renal tubular acidosis
|
| G |
Ca2 |
carbonic anhydrase 2 |
|
|
ISS |
2 |
88,077,095 |
88,092,223 |
RGD:7240710 |
OMIM |
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 4
|
| G |
Clcn7 |
chloride channel, voltage-sensitive 7 |
|
|
ISS |
10 |
14,379,803 |
14,403,898 |
RGD:7240710 |
OMIM |
Osteopetrosis, Autosomal Recessive 1
|
| G |
Tcirg1 |
T-cell, immune regulator 1, ATPase, H+ transporting, lysosomal V0 subunit A3 |
|
|
ISS |
1 |
206,420,106 |
206,429,495 |
RGD:7240710 |
OMIM |
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 2
|
| G |
Tnfsf11 |
tumor necrosis factor (ligand) superfamily, member 11 |
|
|
ISS |
15 |
59,397,837 |
59,428,014 |
RGD:7240710 |
OMIM |
Osteopetrosis, Autosomal Recessive 6
|
| G |
Plekhm1 |
pleckstrin homology domain containing, family M (with RUN domain) member 1 |
|
|
ISS |
10 |
92,555,565 |
92,603,324 |
RGD:7240710 |
OMIM |
Osteopetrosis, Autosomal Recessive 7
|
| G |
Tnfrsf11a |
tumor necrosis factor receptor superfamily, member 11a, NFKB activator |
|
|
ISS |
13 |
11,958,002 |
12,014,371 |
RGD:7240710 |
OMIM |
Osteoporosis-pseudoglioma syndrome
|
| G |
Lrp5 |
low density lipoprotein receptor-related protein 5 |
|
|
ISS |
1 |
206,102,750 |
206,206,350 |
RGD:7240710 |
OMIM |
Oto-Palato-digital syndrome type 1
|
| G |
Flna |
filamin A, alpha |
|
|
ISS |
X |
160,362,334 |
160,385,626 |
RGD:7240710 |
OMIM |
Oto-palato-digital syndrome, type 2
|
| G |
Flna |
filamin A, alpha |
|
|
ISS |
X |
160,362,334 |
160,385,626 |
RGD:7240710 |
OMIM |
OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA
|
| G |
Col11a2 |
collagen, type XI, alpha 2 |
|
|
ISS |
20 |
4,924,452 |
4,953,310 |
RGD:7240710 |
OMIM |
| G |
Col2a1 |
collagen, type II, alpha 1 |
|
|
ISS |
7 |
136,679,219 |
136,707,976 |
RGD:7240710 |
OMIM |
Parietal Foramina With Cleidocranial Dysplasia
|
| G |
Msx2 |
msh homeobox 2 |
|
|
ISS |
17 |
17,243,262 |
17,248,927 |
RGD:7240710 |
OMIM |
Pierre Robin syndrome with fetal chondrodysplasia
|
| G |
Col11a2 |
collagen, type XI, alpha 2 |
|
|
ISS |
20 |
4,924,452 |
4,953,310 |
RGD:7240710 |
OMIM |
Platyspondylic Lethal Skeletal Dysplasia, Torrance Type
|
| G |
Col2a1 |
collagen, type II, alpha 1 |
|
|
ISS |
7 |
136,679,219 |
136,707,976 |
RGD:7240710 |
OMIM |
Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy
|
| G |
Trem2 |
triggering receptor expressed on myeloid cells 2 |
|
|
ISS |
9 |
8,059,023 |
8,065,585 |
RGD:7240710 |
OMIM |
| G |
Tyrobp |
Tyro protein tyrosine kinase binding protein |
|
|
ISS |
1 |
85,365,371 |
85,369,224 |
RGD:7240710 |
OMIM |
Pseudoachondroplasia
|
| G |
Comp |
cartilage oligomeric matrix protein |
|
|
ISS |
|
|
|
RGD:7240710 |
OMIM |
PSEUDOHYPOPARATHYROIDISM, TYPE IA
|
| G |
Gnas |
GNAS complex locus |
|
|
ISS |
3 |
165,213,399 |
165,214,551 |
RGD:7240710 |
OMIM |
Pycnodysostosis
|
| G |
Ctsk |
cathepsin K |
|
|
ISS |
2 |
190,394,854 |
190,405,668 |
RGD:7240710 |
OMIM |
Raine syndrome
|
| G |
Fam20c |
family with sequence similarity 20, member C |
|
|
ISS |
12 |
16,340,407 |
16,399,325 |
RGD:7240710 |
OMIM |
Rhizomelic chondrodysplasia punctata, type 1
|
| G |
Pex7 |
peroxisomal biogenesis factor 7 |
|
|
ISS |
1 |
15,099,265 |
15,163,734 |
RGD:7240710 |
OMIM |
Rhizomelic chondrodysplasia punctata, type 2
|
| G |
Gnpat |
glyceronephosphate O-acyltransferase |
|
|
ISS |
19 |
55,033,777 |
55,059,491 |
RGD:7240710 |
OMIM |
Rhizomelic chondrodysplasia punctata, type 3
|
| G |
Agps |
alkylglycerone phosphate synthase |
|
|
ISS |
|
|
|
RGD:7240710 |
OMIM |
Schimke immunoosseous dysplasia
|
| G |
Smarcal1 |
Swi/SNF related matrix associated, actin dependent regulator of chromatin, subfamily a-like 1 |
|
|
ISS |
9 |
71,780,870 |
71,827,780 |
RGD:7240710 |
OMIM |
Schneckenbecken dysplasia
|
| G |
Slc35d1 |
solute carrier family 35 (UDP-glucuronic acid/UDP-N-acetylgalactosamine dual transporter), member D1 |
|
|
ISS |
5 |
124,107,948 |
124,154,018 |
RGD:7240710 |
OMIM |
Short Rib-Polydactyly Syndrome
|
| G |
Dync2h1 |
dynein cytoplasmic 2 heavy chain 1 |
|
|
ISS |
8 |
3,826,843 |
4,072,644 |
RGD:7240710 |
OMIM |
| G |
Nek1 |
NIMA-related kinase 1 |
|
|
ISS |
16 |
32,317,987 |
32,438,010 |
RGD:7240710 |
OMIM |
Short rib-polydactyly syndrome, Verma-Naumoff type
|
| G |
Dync2h1 |
dynein cytoplasmic 2 heavy chain 1 |
|
|
ISS |
8 |
3,826,843 |
4,072,644 |
RGD:7240710 |
OMIM |
Smith-McCort Dysplasia
|
| G |
Dym |
dymeclin |
|
|
ISS |
18 |
71,889,053 |
72,188,251 |
RGD:7240710 |
OMIM |
Spondylocheirodysplasia, Ehlers-Danlos Syndrome-Like
|
| G |
Slc39a13 |
solute carrier family 39 (zinc transporter), member 13 |
|
|
ISS |
3 |
75,421,153 |
75,429,058 |
RGD:7240710 |
OMIM |
Spondyloepimetaphyseal Dysplasia, Matrilin-3 Related
|
| G |
Matn3 |
matrilin 3 |
|
|
ISS |
6 |
32,439,372 |
32,459,031 |
RGD:7240710 |
OMIM |
Spondyloepimetaphyseal Dysplasia, Missouri Type
|
| G |
Mmp13 |
matrix metallopeptidase 13 |
|
|
ISS |
8 |
4,158,887 |
4,169,166 |
RGD:7240710 |
OMIM |
Spondyloepimetaphyseal Dysplasia, Pakistani Type
|
| G |
Papss2 |
3'-phosphoadenosine 5'-phosphosulfate synthase 2 |
|
|
ISS |
1 |
236,592,414 |
236,677,379 |
RGD:7240710 |
OMIM |
Spondyloepiphyseal Dysplasia Tarda, X-Linked
|
| G |
Trappc2 |
trafficking protein particle complex 2 |
|
|
ISS |
X |
48,690,381 |
48,701,588 |
RGD:7240710 |
OMIM |
SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS
|
| G |
Chst3 |
carbohydrate (chondroitin 6) sulfotransferase 3 |
|
|
ISS |
20 |
27,480,448 |
27,482,990 |
RGD:7240710 |
OMIM |
Spondyloepiphyseal dysplasia, congenita
|
| G |
Col2a1 |
collagen, type II, alpha 1 |
|
|
ISS |
7 |
136,679,219 |
136,707,976 |
RGD:7240710 |
OMIM |
Spondyloepiphyseal Dysplasia, Kimberley Type
|
| G |
Acan |
aggrecan |
|
|
ISS |
1 |
134,787,341 |
134,848,992 |
RGD:7240710 |
OMIM |
SPONDYLOEPIPHYSEAL DYSPLASIA, MAROTEAUX TYPE
|
| G |
Trpv4 |
transient receptor potential cation channel, subfamily V, member 4 |
|
|
ISS |
12 |
43,226,933 |
43,265,889 |
RGD:7240710 |
OMIM |
Spondylometaepiphyseal Dysplasia, Short Limb-Hand Type
|
| G |
Ddr2 |
discoidin domain receptor tyrosine kinase 2 |
|
|
ISS |
13 |
85,801,449 |
85,846,636 |
RGD:7240710 |
OMIM |
| G |
Tkt |
transketolase |
|
|
ISS |
16 |
5,908,759 |
5,933,695 |
RGD:7240710 |
OMIM |
Spondylometaphyseal dysplasia, Kozlowski type
|
| G |
Trpv4 |
transient receptor potential cation channel, subfamily V, member 4 |
|
|
ISS |
12 |
43,226,933 |
43,265,889 |
RGD:7240710 |
OMIM |
SPONDYLOPERIPHERAL DYSPLASIA
|
| G |
Col2a1 |
collagen, type II, alpha 1 |
|
|
ISS |
7 |
136,679,219 |
136,707,976 |
RGD:7240710 |
OMIM |
Strudwick syndrome
|
| G |
Col2a1 |
collagen, type II, alpha 1 |
|
|
ISS |
7 |
136,679,219 |
136,707,976 |
RGD:7240710 |
OMIM |
Stuve-Wiedemann syndrome
|
| G |
Lifr |
leukemia inhibitory factor receptor alpha |
|
|
ISS |
2 |
56,426,058 |
56,477,198 |
RGD:7240710 |
OMIM |
Thanatophoric Dysplasia
|
| G |
Fgfr3 |
fibroblast growth factor receptor 3 |
|
|
ISS |
14 |
82,683,191 |
82,697,229 |
RGD:2289863 |
RGD |
| G |
Fgfr3 |
fibroblast growth factor receptor 3 |
|
|
ISS |
14 |
82,683,191 |
82,697,229 |
RGD:7240710 |
OMIM |
Thanatophoric dysplasia, type 1
|
| G |
Fgfr3 |
fibroblast growth factor receptor 3 |
|
|
ISS |
14 |
82,683,191 |
82,697,229 |
RGD:7240710 |
OMIM |
Thanatophoric dysplasia, type 2
|
| G |
Fgfr3 |
fibroblast growth factor receptor 3 |
|
|
ISS |
14 |
82,683,191 |
82,697,229 |
RGD:7240710 |
OMIM |
TRICHORHINOPHALANGEAL SYNDROME, TYPE I
|
| G |
Trps1 |
trichorhinophalangeal syndrome I |
|
|
ISS |
7 |
86,855,378 |
87,076,668 |
RGD:7240710 |
OMIM |
Tumoral Calcinosis, Hyperphosphatemic, Familial
|
| G |
Fgf23 |
fibroblast growth factor 23 |
|
|
ISS |
4 |
163,468,604 |
163,476,325 |
RGD:7240710 |
OMIM |
| G |
Galnt3 |
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 3 (GalNAc-T3) |
|
|
ISS |
3 |
48,026,128 |
48,049,883 |
RGD:7240710 |
OMIM |
| G |
Kl |
Klotho |
|
|
ISS |
12 |
3,732,712 |
3,772,371 |
RGD:7240710 |
OMIM |
Van Buchem disease type 2
|
| G |
Lrp5 |
low density lipoprotein receptor-related protein 5 |
|
|
ISS |
1 |
206,102,750 |
206,206,350 |
RGD:7240710 |
OMIM |
Wolcott-Rallison syndrome
|
| G |
Eif2ak3 |
eukaryotic translation initiation factor 2 alpha kinase 3 |
|
|
ISS |
4 |
104,016,940 |
104,078,261 |
RGD:7240710 |
OMIM |
Term paths to the root
| Path 1 |
Diseases |
30711 |
 |
Musculoskeletal Diseases |
1840 |
 |
Bone Diseases |
755 |
 |
Bone Diseases, Developmental |
390 |
 |
Osteochondrodysplasias |
192 |
 |
ATELOSTEOGENESIS, TYPE III |
2 |
 |
Achondroplasia + |
13 |
 |
Acquired Hyperostosis Syndrome |
0 |
 |
Acrodysostosis |
0 |
 |
Acrodysplasia scoliosis |
0 |
 |
Acrodysplasia with ossification abnormalities, short stature, and fibular hypoplasia |
0 |
 |
Acromesomelic dysplasia |
0 |
 |
Acromesomelic dysplasia Campailla-Martinelli type |
0 |
 |
Acromesomelic dysplasia Hunter-Thompson type |
1 |
 |
Acropectorovertebral Dysplasia, F-Form |
0 |
 |
Akaba Hayasaka syndrome |
0 |
 |
Anauxetic dysplasia |
1 |
 |
Atelosteogenesis type 2 |
1 |
 |
Atelosteogenesis, type 1 |
2 |
 |
Auriculoosteodysplasia |
0 |
 |
Boomerang dysplasia |
2 |
 |
Brachyolmia |
0 |
 |
Brachyolmia Type 2 |
0 |
 |
Brachyolmia Type 3 |
1 |
 |
Brachyolmia, recessive Hobaek type |
0 |
 |
CODAS syndrome |
0 |
 |
Camurati-Engelmann Syndrome + |
1 |
 |
Cantu syndrome |
0 |
 |
Cartilage hair hypoplasia like syndrome |
0 |
 |
Cartilage-hair hypoplasia |
1 |
 |
Chondrodysplasia Calcificans Metaphysealis |
0 |
 |
Chondrodysplasia Punctata + |
11 |
 |
Chondrodysplasia, Grebe type |
1 |
 |
Chondrodysplasia, Lethal, with Long Bone Angulation and Mixed Bone Density |
0 |
 |
Chondrodysplasia, Megarbane-Dagher-Melki Type |
0 |
 |
Chondrodysplasia, blomstrand type |
0 |
 |
Cleidocranial Dysplasia + |
3 |
 |
Cleidorhizomelic syndrome |
0 |
 |
Cloverleaf skull micromelia thoracic dysplasia |
0 |
 |
Collagenopathy, type 2 alpha 1 |
0 |
 |
Coloboma of Alar-nasal cartilages with telecanthus |
0 |
 |
Combined Immunodeficiency with Autoimmunity and Spondylometaphyseal Dysplasia |
0 |
 |
Craniodiaphyseal Dysplasia |
0 |
 |
Craniodiaphyseal Dysplasia, Autosomal Dominant |
0 |
 |
Czech dysplasia, metatarsal type |
0 |
 |
Dyggve-Melchior-Clausen syndrome |
1 |
 |
Dyschondrosteosis and Nephritis |
0 |
 |
Eiken Skeletal Dysplasia |
0 |
 |
Ellis-Van Creveld Syndrome + |
6 |
 |
Enchondromatosis |
0 |
 |
Epiphyseal Dysplasia of Femoral Head, Myopia, and Deafness |
0 |
 |
Epiphyseal Dysplasia, Baumann Type |
0 |
 |
Epiphyseal Dysplasia, Multiple, with Miniepiphyses |
0 |
 |
Epiphyseal Dysplasia, Multiple, with Myopathy |
0 |
 |
Epiphyseal Dysplasia, Multiple, with Myopia and Conductive Deafness |
1 |
 |
Epiphyseal Dysplasia, Multiple, with Severe Proximal Femoral Dysplasia |
0 |
 |
Epiphyseal dysplasia, multiple, 1 |
1 |
 |
Epiphyseal dysplasia, multiple, 2 |
1 |
 |
Epiphyseal dysplasia, multiple, 3 |
1 |
 |
Epiphyseal dysplasia, multiple, 4 |
1 |
 |
Epiphyseal dysplasia, multiple, 5 |
1 |
 |
Fairbank disease |
1 |
 |
Faye-Petersen Ward Carey syndrome |
0 |
 |
Fibrous Dysplasia of Bone + |
6 |
 |
Fraser Jequier Chen syndrome |
0 |
 |
Frontometaphyseal dysplasia |
1 |
 |
Frontootopalatodigital Osteodysplasia |
0 |
 |
Ghosal Hematodiaphyseal Dysplasia |
1 |
 |
Greenberg dysplasia |
0 |
 |
HEM dysplasia |
0 |
 |
HYDROPS-ECTOPIC CALCIFICATION-MOTH-EATEN SKELETAL DYSPLASIA |
1 |
 |
HYPEROSTOSIS CORTICALIS GENERALISATA, BENIGN FORM OF WORTH, WITH TORUS PALATINUS |
1 |
 |
Heterotopia, Periventricular Nodular, with Frontometaphyseal Dysplasia |
0 |
 |
Hip Dysplasia, Beukes Type |
0 |
 |
Hyperostosis Frontalis Interna + |
0 |
 |
Hyperostosis, Cortical, Congenital + |
7 |
 |
Hypochondrogenesis |
0 |
 |
Hypoparathyroidism-retardation-dysmorphism syndrome |
1 |
 |
Intrauterine Growth Retardation, Metaphyseal Dysplasia, Adrenal Hypoplasia Congenita, And Genital Anomalies |
1 |
 |
Jansen type metaphyseal chondrodysplasia |
0 |
 |
Jequier Kozlowski skeletal dysplasia |
0 |
 |
Kashin-Beck Disease |
0 |
 |
Kniest-Like Dysplasia with Pursed Lips and Ectopia Lentis |
0 |
 |
Kozlowski Celermajer Tink syndrome |
0 |
 |
Kozlowski Tsuruta Taki syndrome |
0 |
 |
Langer mesomelic dysplasia |
0 |
 |
Langer-Giedion Syndrome + |
1 |
 |
Laplane Fontaine Lagardere syndrome |
0 |
 |
Larsen syndrome, dominant type |
2 |
 |
Larsen-Like Syndrome |
0 |
 |
Leri-Weil syndrome |
0 |
 |
Leukoencephalopathy With Metaphyseal Chondrodysplasia |
0 |
 |
Lowry Wood syndrome |
0 |
 |
Macrocephaly with Multiple Epiphyseal Dysplasia and Distinctive Facies |
0 |
 |
Madelung Deformity |
0 |
 |
Marshall syndrome |
1 |
 |
Megaepiphyseal dwarfism |
0 |
 |
Mental Retardation, Skeletal Dysplasia, and Abducens Palsy |
0 |
 |
Mesomelic Dwarfism of Hypoplastic Tibia and Radius Type |
0 |
 |
Mesomelic Dysplasia, Savarirayan Type |
0 |
 |
Mesomelic dwarfism Reinhardt Pfeiffer type |
0 |
 |
Metaphyseal Anadysplasia 1 |
0 |
 |
Metaphyseal Anadysplasia 2 |
1 |
 |
Metaphyseal Chondrodysplasia with Retinitis Pigmentosa |
0 |
 |
Metaphyseal Chondrodysplasia, Kaitila Type |
0 |
 |
Metaphyseal Chondrodysplasia, Pena Type |
0 |
 |
Metaphyseal Dysplasia with Maxillary Hypoplasia and Brachydactyly |
0 |
 |
Metaphyseal Dysplasia without Hypotrichosis |
1 |
 |
Metaphyseal Dysplasia, Anetoderma, and Optic Atrophy |
0 |
 |
Metaphyseal Dysplasia, Braun-Tinschert Type |
0 |
 |
Metaphyseal anadysplasia |
0 |
 |
Metaphyseal chondrodysplasia Schmid type |
1 |
 |
Metaphyseal chondrodysplasia Spahr type |
0 |
 |
Metaphyseal chondrodysplasia with cone-shaped epiphyses, normal hair, and normal hands |
0 |
 |
Metaphyseal undermodeling, spondylar dysplasia, and overgrowth |
0 |
 |
Metatropic dwarfism |
1 |
 |
Microcephalic Osteodysplastic Primordial Dwarfism, Type II |
1 |
 |
Microcephalic osteodysplastic primordial dwarfism, type 1 |
0 |
 |
Microcephaly-Micromelia Syndrome |
0 |
 |
Micromelic dwarfism Fryns type |
0 |
 |
Micromelic dysplasia, congenital, with dislocation of radius |
0 |
 |
Multiple Congenital Anomalies Syndrome with Cloverleaf Skull |
0 |
 |
Multiple Epiphyseal Dysplasia with Robin Phenotype |
0 |
 |
Nance Sweeney chondrodysplasia + |
2 |
 |
Nievergelt syndrome |
0 |
 |
Nivelon Nivelon Mabille syndrome |
0 |
 |
Omodysplasia 2 |
0 |
 |
Omodysplasia type 1 |
0 |
 |
Opsismodysplasia |
0 |
 |
Osebold Skeletal Dysplasia Osteolysis Syndrome |
0 |
 |
Osteoarthritis with Mild Chondrodysplasia |
1 |
 |
Osteochondrodysplasia, Rhizomelic, with Callosal Agenesis, Thrombocytopenia, Hydrocephalus, and Hypertension |
0 |
 |
Osteochondroma + |
5 |
 |
Osteodysplasia, Familial, Anderson Type |
0 |
 |
Osteodysplasty, Precocious, Of Danks, Mayne, And Kozlowski |
0 |
 |
Osteogenesis Imperfecta + |
16 |
 |
Osteoglophonic dwarfism |
1 |
 |
Osteosclerosis + |
27 |
 |
Oto-Palato-digital syndrome type 1 |
1 |
 |
Oto-palato-digital syndrome, type 2 |
1 |
 |
Otopalatodigital Spectrum Disorder |
0 |
 |
Pelvis-Shoulder Dysplasia |
0 |
 |
Pierre Robin syndrome with fetal chondrodysplasia |
1 |
 |
Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy |
2 |
 |
Polydysspondyly |
0 |
 |
Pubic Bone Dysplasia |
0 |
 |
Pycnodysostosis |
1 |
 |
Pyle disease |
0 |
 |
Roifman syndrome |
0 |
 |
SPONDYLOEPIPHYSEAL DYSPLASIA, MAROTEAUX TYPE |
1 |
 |
SPONDYLOPERIPHERAL DYSPLASIA |
1 |
 |
Schaefer Stein Oshman syndrome |
0 |
 |
Schimke immunoosseous dysplasia |
1 |
 |
Schneckenbecken dysplasia |
1 |
 |
Short Rib-Polydactyly Syndrome + |
3 |
 |
Short stature syndrome, Brussels type |
0 |
 |
Situs inversus totalis with cystic dysplasia of kidneys and pancreas |
0 |
 |
Sketetal dysplasia coarse facies mental retardation |
0 |
 |
Slipped Capital Femoral Epiphyses + |
0 |
 |
Smith-McCort Dysplasia |
1 |
 |
Spinal Dysplasia, Anhalt Type |
0 |
 |
Spondylo-Megaepiphyseal-Metaphyseal Dysplasia |
0 |
 |
Spondylocheirodysplasia, Ehlers-Danlos Syndrome-Like |
1 |
 |
Spondylodysplasia And Premature Pubarche |
0 |
 |
Spondyloenchondrodysplasia |
0 |
 |
Spondyloepimetaphyseal Dysplasia With Abnormal Dentition |
0 |
 |
Spondyloepimetaphyseal Dysplasia With Joint Laxity |
0 |
 |
Spondyloepimetaphyseal Dysplasia, Irapa Type |
0 |
 |
Spondyloepimetaphyseal Dysplasia, Matrilin-3 Related |
1 |
 |
Spondyloepimetaphyseal Dysplasia, Missouri Type |
1 |
 |
Spondyloepimetaphyseal Dysplasia, Pakistani Type |
1 |
 |
Spondyloepimetaphyseal Dysplasia, Shohat Type |
0 |
 |
Spondyloepimetaphyseal Dysplasia, X-Linked |
0 |
 |
Spondyloepimetaphyseal dysplasia with hypotrichosis |
0 |
 |
Spondyloepimetaphyseal dysplasia with multiple dislocations |
0 |
 |
Spondyloepimetaphyseal dysplasia, Genevieve type |
0 |
 |
Spondyloepimetaphyseal dysplasia, sponastrime type |
0 |
 |
Spondyloepiphyseal Dysplasia Tarda with Characteristic Facies |
0 |
 |
Spondyloepiphyseal Dysplasia Tarda with Mental Retardation |
0 |
 |
Spondyloepiphyseal Dysplasia Tarda, Autosomal Dominant |
0 |
 |
Spondyloepiphyseal Dysplasia Tarda, Autosomal Recessive |
0 |
 |
Spondyloepiphyseal Dysplasia Tarda, Autosomal Recessive, Leroy-Spranger Type |
0 |
 |
Spondyloepiphyseal Dysplasia Tarda, X-Linked |
1 |
 |
Spondyloepiphyseal Dysplasia With Coronal Craniosynostosis, Cataracts, Cleft Palate, And Mental Retardation |
0 |
 |
Spondyloepiphyseal Dysplasia With Punctate Corneal Dystrophy |
0 |
 |
Spondyloepiphyseal Dysplasia with Atlantoaxial Instability |
0 |
 |
Spondyloepiphyseal Dysplasia, Kimberley Type |
1 |
 |
Spondyloepiphyseal Dysplasia, Myopia, And Sensorineural Deafness |
0 |
 |
Spondyloepiphyseal Dysplasia-Brachydactyly and Distinctive Speech |
0 |
 |
Spondyloepiphyseal dysplasia tarda, Toledo type |
0 |
 |
Spondyloepiphyseal dysplasia, Omani type + |
1 |
 |
Spondyloepiphyseal dysplasia, congenita |
1 |
 |
Spondylomegaepiphyseal Dysplasia With Upper Limb Mesomelia, Punctate Calcifications, And Deafness |
0 |
 |
Spondylometaepiphyseal Dysplasia, Short Limb-Hand Type |
2 |
 |
Spondylometaphyseal Dysplasia with Cone-Rod Dystrophy |
0 |
 |
Spondylometaphyseal Dysplasia, Type A4 |
0 |
 |
Spondylometaphyseal Dysplasia, X-Linked |
0 |
 |
Spondylometaphyseal dysplasia with bowed forearms and facial dysmorphism |
0 |
 |
Spondylometaphyseal dysplasia with dentinogenesis imperfecta |
0 |
 |
Spondylometaphyseal dysplasia, 'corner fracture' type |
0 |
 |
Spondylometaphyseal dysplasia, Algerian type |
0 |
 |
Spondylometaphyseal dysplasia, Kozlowski type |
1 |
 |
Spondylometaphyseal dysplasia, Sedaghatian type |
0 |
 |
Spondylometaphyseal dysplasia, axial |
0 |
 |
Spondylometaphyseal dysplasia, east-African type |
0 |
 |
Spondyloocular Syndrome, Autosomal Recessive |
0 |
 |
Spondyloperipheral dysplasia short ulna |
0 |
 |
Spondylospinal Thoracic Dysostosis |
0 |
 |
Strudwick syndrome |
1 |
 |
Stuve-Wiedemann syndrome |
1 |
 |
Teebi Naguib Al Awadi syndrome |
0 |
 |
Ter Haar syndrome |
0 |
 |
Terminal Osseous Dysplasia and Pigmentary Defects |
0 |
 |
Thoracolaryngopelvic dysplasia |
0 |
 |
Tracheobronchopathia osteoplastica |
0 |
 |
Trichoscyphodysplasia |
0 |
 |
Ulna metaphyseal dysplasia syndrome |
0 |
 |
Upington disease |
0 |
 |
Verloes Bourguignon syndrome |
0 |
 |
Verloes Van Maldergem Marneffe syndrome |
0 |
 |
Vitreoretinopathy with Phalangeal Epiphyseal Dysplasia |
0 |
 |
Wolcott-Rallison syndrome |
1 |
 |
| |
|